Project: AD Scanner for Prognosis of Alzheimer’s Disease by Blood Analysis

Acronym AD SCANNER (Reference Number: 12765)
Duration 25/02/2019 - 26/02/2021
Project Topic The main outcome is a novel, fast (<1 h) and inexpensive (<10 € per sample) blood assay for assessing the Alzheimer's disease (AD) progression rate or even risk of developing AD. The main goal is to create a novel analytical device, the AD Scanner, for measuring the level of protein biomarkers (abnormal proteoforms) in human blood plasma, serum or cerebrospinal fluid around the isoelectric point (pI) ˜7.35. The AD Scanner will be highly valuable in both pre-clinical research and the hospital lab
Network Eurostars 2
Call Eurostars Cut–off 10

Project partner

Number Name Role Country
1 Biomotif AB Coordinator Sweden
2 Karolinska Institutet Partner Sweden
3 Spectrometry Vision BV Partner Netherlands
4 Paraytec Ltd Partner United Kingdom
5 VUMC Partner Netherlands